Verrica Pharmaceuticals Executives Make Significant Stock Purchases
Executives at Verrica Pharmaceuticals, including Paul B Manning, John J Kirby, Jayson Rieger, and David Zawitz, have made substantial stock purchases, as reported in SEC Form 4 filings. Manning acquired shares worth $17,505,157, Kirby $15,001, Rieger $400,114, and Zawitz $42,425. These transactions reflect significant investments in the company's common stock by its leadership.
| Reporter Name | Relationship | Type | Amount | SEC Filing |
|---|---|---|---|---|
| Manning Paul B | Director, 10% Owner | Purchase | $17,505,157 | Form 4 |
| Kirby John J. | Interim CFO, 10% Owner | Purchase | $15,001 | Form 4 |
| Rieger Jayson | CEO and President, 10% Owner | Purchase | $400,114 | Form 4 |
| Zawitz David | Chief Operating Officer, 10% Owner | Purchase | $42,425 | Form 4 |
Several executives at Verrica Pharmaceuticals, including directors and officers, have recently made substantial purchases of the company's common stock, as reported in SEC Form 4 filings.
Paul B Manning, a director and 10% owner, acquired 4,126,142 shares at $4.2425 each, totaling $17,505,157. Post-transaction, Manning's direct ownership stands at 3,958,189 shares, with an additional 3,974,029 shares held indirectly through various trusts and entities.
Interim CFO and 10% owner Kirby John J. purchased 3,536 shares at the same price, amounting to $15,001, bringing his direct ownership to 8,962 shares.
CEO and President Jayson Rieger, also a 10% owner, bought 94,311 shares at $4.2425 per share, for a total of $400,114. This transaction increased Rieger's direct holdings to 182,593 shares, with an additional 705 shares held indirectly.
Chief Operating Officer David Zawitz, another 10% owner, acquired 10,000 shares at $4.2425 each, totaling $42,425, and now directly owns 21,000 shares.
